CHEBI:66919 - ruxolitinib

ChEBI IDCHEBI:66919
ChEBI Nameruxolitinib
Stars
DefinitionA pyrazole substituted at position 1 by a 2-cyano-1-cyclopentylethyl group and at position 3 by a pyrrolo[2,3-d]pyrimidin-4-yl group. Used as the phosphate salt for the treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essential thrombocythemia myelofibrosis.
Last Modified22 February 2017
SubmitterSteve
DownloadsMolfile
FormulaC17H18N6
Net Charge0
Average Mass306.373
Monoisotopic Mass306.15929
SMILESN#CC[C@H](C1CCCC1)n1cc(-c2ncnc3nccc23)cn1
InChIInChI=1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)/t15-/m1/s1
InChIKeyHFNKQEVNSGCOJV-OAHLLOKOSA-N
Wikipedia
Roles Classification
Biological Roles:
immunosuppressive agent  An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response.
antiviral agent  A substance that destroys or inhibits replication of viruses.
antimicrobial agent  A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
anti-HIV agent  An antiviral agent that destroys or inhibits the replication of the human immunodeficiency virus.
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor  An EC 2.7.10.* (protein-tyrosine kinase) inhibitor that specifically blocks the action of non-specific protein-tyrosine kinase (EC 2.7.10.2).
Applications:
immunosuppressive agent  An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response.
antipsoriatic  A drug used to treat psoriasis.
antirheumatic drug  A drug used to treat rheumatoid arthritis.
antineoplastic agent  A substance that inhibits or prevents the proliferation of neoplasms.
antifibrotic agent  Any agent which acts to reduce fibrosis.
anti-anaemic agent  A compound which increases either the number of red cells or the amount of haemoglobin in the blood.
dermatologic drug  A drug used to treat or prevent skin disorders or for the routine care of skin.
ChEBI Ontology
Outgoing Relation(s)
ruxolitinib (CHEBI:66919) has role anti-anaemic agent (CHEBI:75835)
ruxolitinib (CHEBI:66919) has role anti-HIV agent (CHEBI:64946)
ruxolitinib (CHEBI:66919) has role antifibrotic agent (CHEBI:233423)
ruxolitinib (CHEBI:66919) has role antimicrobial agent (CHEBI:33281)
ruxolitinib (CHEBI:66919) has role antineoplastic agent (CHEBI:35610)
ruxolitinib (CHEBI:66919) has role antipsoriatic (CHEBI:50748)
ruxolitinib (CHEBI:66919) has role antirheumatic drug (CHEBI:35842)
ruxolitinib (CHEBI:66919) has role antiviral agent (CHEBI:22587)
ruxolitinib (CHEBI:66919) has role dermatologic drug (CHEBI:50177)
ruxolitinib (CHEBI:66919) has role EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor (CHEBI:76617)
ruxolitinib (CHEBI:66919) has role immunosuppressive agent (CHEBI:35705)
ruxolitinib (CHEBI:66919) is a nitrile (CHEBI:18379)
ruxolitinib (CHEBI:66919) is a pyrazoles (CHEBI:26410)
ruxolitinib (CHEBI:66919) is a pyrrolopyrimidine (CHEBI:38670)
Incoming Relation(s)
ruxolitinib phosphate (CHEBI:66917) has part ruxolitinib (CHEBI:66919)
IUPAC Name 
(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile
INN  Source
ruxolitinibKEGG DRUG
Synonyms  Source
INC-424ChEMBL
INC424ChEMBL
INCB-018424ChEMBL
INCB018424ChemIDplus
INCB-18424ChEMBL
Ruxolitinib, s-ChEMBL
Manual XrefsDatabases
4190DrugCentral
D09959KEGG DRUG
LSM-1139LINCS
RuxolitinibWikipedia
US2008312258Patent
US2010190981Patent
Registry NumbersSources
Reaxys:18703668Reaxys
CAS:941678-49-5KEGG DRUG
CAS:941678-49-5ChemIDplus
Citations